|
|
|
|
|
|
|
|
|
 |
The state of cell therapies: Filling the gap that separates promise from reality
An executive from Biolife discussed the state of the cell therapy industry, urging innovation.
Read Now.
|
 |
To build or not to build: Biomanufacturing considerations in a shifting economy
An executive from Charles River poises the question to delegates at the Cell Summit in Indianapolis.
Read Now.
|
 |
Shaken or stirred? Maintaining healthy cells while avoiding sedimentation
An expert from Bayer discussed aspects operators must consider when mixing and filling during cell therapy manufacturing.
Read Now.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%20flat%20comp.gif?upscale=true&width=1380&upscale=true&name=Vela%20Labs%202025%20Banner%20(728x90)%20flat%20comp.gif)
